Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘16
376
9 20 11 0.15%
377
9 33 24 28%
378
8 41 33 50.7%
ZVRA icon
379
Zevra Therapeutics
ZVRA
$606M
8 20 12 95.3%
380
8 14 6 43.8%
381
8 38 30 5.33%
382
8 27 19 346%
383
8 25 17 31.2%
384
8 37 29 32.8%
385
8 31 23 24.1%
SRCE icon
386
1st Source
SRCE
$1.42B
8 38 30 82.1%
387
8 40 32 315%
388
8 59 51 23%
389
8 37 29 59.5%
390
8 45 37 63.7%
391
8 14 6 108%
392
8 28 20 19.2%
393
8 151 143 58.6%
394
8 76 68 20.4%
395
8 35 27 79.6%
396
8 23 15 35.2%
397
8 17 9 19.8%
398
8 25 17 52.2%
399
8 55 47 60.7%
400
8 47 39 96.4%